Ruan, Jing
Zuo, Wei
Chen, Miao
Yang, Chen
Han, Bing
Funding for this research was provided by:
Natural Science Foundation of Beijing Municipality (7192168)
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and Peking Union Medical College (2016-I2M-3-004)
the National Key Research and Development Program of China (2016YFC0901500)
Article History
Received: 31 March 2020
Accepted: 7 September 2020
First Online: 17 September 2020
Change Date: 2 November 2020
Change Type: Correction
Change Details: The article ���Eltrombopag is effective in patients with relapse/refractory aplastic anemia���report from a single center in China���.
Compliance with ethical standards
:
: The authors declare that they have no conflicts of interest.
: This study was approved by the ethics committee of Peking Union Medical College Hospital and was conducted in accordance with the Declaration of Helsinki.
: Written informed consent to participate was signed by all individual participants included in the study before data collected.
: Written informed consent for the publication of identifying images or other personal or clinical details was obtained from all of the participants in the study.